superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2019-03-31
- Valid until
- 2019-06-30
- Published
- 2019-05-01
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 2,678,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Amgen quarterly operating income: 2,472,000,000 United States dollar", as of 2019-03-31 (until 2019-06-30). Claim clm_ADA46DB14C4E, https://asof.is/claim/clm_ADA46DB14C4E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815419000018/0000318154-19-000018-index.htm.
APA
AsOf. (2019). Amgen quarterly operating income: 2,472,000,000 United States dollar (as of 2019-03-31 (until 2019-06-30)) [Record clm_ADA46DB14C4E]. Retrieved November 8, 2026, from https://asof.is/claim/clm_ADA46DB14C4E (source: https://www.sec.gov/Archives/edgar/data/318154/000031815419000018/0000318154-19-000018-index.htm)
BibTeX
@misc{asof_clm_ADA46DB14C4E,
author = {AsOf},
title = {Amgen quarterly operating income: 2,472,000,000 United States dollar},
year = {2019},
howpublished = {\url{https://asof.is/claim/clm_ADA46DB14C4E}},
note = {Claim clm\_ADA46DB14C4E, as of 2019-03-31 (until 2019-06-30); source: https://www.sec.gov/Archives/edgar/data/318154/000031815419000018/0000318154-19-000018-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_ADA46DB14C4E.md/v1/claims/clm_ADA46DB14C4Esubmit a correction